SCHEMBL19960375

SCHEMBL19960375

Clc1ccc2c(ccc3c4ccccc4c4nc5ccccc5n4c23)c1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HPGD P15428 5/20 0.46
▸ KDM4E B2RXH2 6/20 0.46
▸ MAPT P10636 4/20 0.46
▸ LMNA P02545 1/20 0.46
▸ TP53 P04637 1/20 0.46
▸ POLB P06746 1/20 0.46
▸ HSD17B10 Q99714 1/20 0.46
▸ ALDH1A1 P00352 5/20 0.44
▸ AHR P35869 1/20 0.43
▸ SMN1; SMN2 Q16637 3/20 0.43
▸ KMT2A Q03164 2/20 0.43
▸ MEN1 O00255 1/20 0.43
▸ HCRTR1 O43613 1/20 0.42
▸ CASP1 P29466 1/20 0.42
▸ CASP7 P55210 1/20 0.42
▸ PDE2A O00408 1/20 0.41
▸ PDE10A Q9Y233 1/20 0.41
▸ CYP1A2 P05177 1/20 0.39
▸ CYP3A4 P08684 1/20 0.39
▸ CYP2C9 P11712 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19959756 0.85 KDM4E (0.53) HPGDKDM4EMAPTLMNATP53
SCHEMBL10041698 0.84 ALDH1A1 (0.49) HPGDKDM4EMAPTLMNATP53
SCHEMBL10041700 0.81 HPGD (0.49) HPGDKDM4EMAPTLMNATP53
SCHEMBL19960393 0.81 HPGD (0.56) HPGDKDM4EMAPTLMNATP53
SCHEMBL10041659 0.81 KDM4E (0.51) HPGDKDM4EMAPTLMNATP53
SCHEMBL10041662 0.81 HPGD (0.49) HPGDKDM4EMAPTLMNATP53
SCHEMBL19960386 0.80 KDM4E (0.44) HPGDKDM4EMAPTLMNATP53
SCHEMBL19959763 0.78 KDM4E (0.49) HPGDKDM4EMAPTLMNATP53
SCHEMBL22456749 0.78 HPGD (0.44) HPGDKDM4EMAPTLMNATP53
SCHEMBL19960224 0.78 KDM4E (0.44) HPGDKDM4EMAPTLMNATP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10700289-B2 Heterocyclic compound and organic light emitting element comprising same LG CHEM, LTD. (KR) 2020-06-30 — — US disclosed
US-20180076395-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME LG CHEM, LTD. (KR) 2018-03-15 — — US disclosed
US-20180076395-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME LG CHEM, LTD. (KR) 2018-03-15 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180076395-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME CRY1, CRY2, PER2 HPGD 2982/4885KDM4E 1997/4885MAPT 1310/4885
US-10700289-B2 Heterocyclic compound and organic light emitting element comprising same CRY1, CRY2, PER2 HPGD 2982/4885KDM4E 1997/4885MAPT 1310/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback